HLA-G/ILT-4 engagement via ERK signaling may be involved in the upregulation of vascular endothelial growth factor C (VEGF-C) expression in non-small cell lung cancer (NSCLC) cells (41). The gene discussed is LILRB2; the disease is non-small cell lung carcinoma.